Local drug release systems in endometriosis

Gynecological Endocrinology

Volumn 23, Issue 11, 2007, Pages 662-664

  Petraglia, Felice ^a   Luisi, Stefano ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DANAZOL; GESTRINONE; GONADORELIN AGONIST; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE;

ADENOMYOSIS; CONTRACEPTION; DEVICE REMOVAL; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG CHOICE; DRUG EFFICACY; DRUG RELEASE; DYSMENORRHEA; DYSPAREUNIA; EDITORIAL; ENDOMETRIOSIS; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MENORRHAGIA; PATIENT COMPLIANCE; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; SPOTTING; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, INTRAVAGINAL; DANAZOL; ENDOMETRIOSIS; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; LEVONORGESTREL; UTERUS;

EID: 36248981505     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590701582216     Document Type: Editorial

References (14)

1. Kennedy S, Bergqvist A, Chapron C, D'Hooghe T, Dunselman G, Greb R, Hummelshoj L, Prentice A, Saridogan E; on behalf of the ESHRE Special Interest Group for Endometriosis and Endometrium Guideline Development Group. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod 2005;20:2698-2704.
2. Maruo T, Laoag-Fernandez JB, Pakarinen P, Murakoshi H, Spitz IM, Johansson E. Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium. Hum Reprod 2001;16:2103-2108.
3. RCOG. The investigation and management of endometriosis. Green-top guidelines no. 24 [Internet], London: Royal College of Obstetricians and Gynaecologists; Oct 2006 [cited Aug 2 2007] Available from: http://www.rcog.org. uk/resources/Public/pdf/endometriosis_gt_24_2006.pdf
4. Lockhat FB, Emembolu JO, Konje JC. The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up. Hum Reprod 2005;20:789-793.
5. Vercellini P, Vigano P, Somigliana E. The role of the levonorgestrel-releasing intrauterine device in the management of symptomatic endometriosis. Curr Opin Obstet Gynecol 2005;17:359-365.
6. Petta CA, Ferriani RA, Abrao MS, Hassan D, Rosa E, Silva JC, Podgaec S, Bahamondes L. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod 2005;20:1993-1998.
7. Fong YF, Singh K. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system. Contraception 1999;60:173-175.
8. Fedele L, Bianchi S, Raffaelli R, Portuese A, Dorta M. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device. Fertil Steril 1997;68:426-429.
9. Critchley HOD, Wang H, Kelly RW, Gebbie AE, Glasier AF. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system. Hum Reprod 1998;13:1210-1217.
10. Igarashi M, Abe Y, Fukuda M, Ando A, Miyasaka M, Yoshida M, Shawki OA. Novel conservative medical therapy for uterine adenomyosis with a danazol-loaded intrauterine device. Fertil Steril 2000;74:412-413.
11. Cobellis L, Razzi S, Fava A, Severi FM, Igarashi M, Petraglia F. A danazol-loaded intrauterine device decreases dysmenorrhea, pelvic pain, and dyspareunia associated with endometriosis. Fertil Steril 2004;82:239-240.
12. Igarashi M, Iizuka M, Abe Y, Ibuki Y. Novel vaginal danazol ring therapy for pelvic endometriosis, in particular deeply infiltrating endometriosis. Hum Reprod 1998;13:1952-1956.
13. Janicki TI, Dmowsky WP. Intravaginal danazol significantly reduces chronic pelvic pain in women with endometriosis. Supplement to the Journal of the Society for Gynecologic Investigation (SGI) 2004 Annual Meeting, abstract no. 266.
14. Razzi S, Luisi S, Calonaci F, Altomare A, Bocchi C, Petraglia F. Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis. Fertil Steril 2007;88:789-794.